Sonoma Pharmaceuticals Announces Fiscal Third Quarter 2018 Financial Results and Conference Call
January 25 2018 - 07:05AM
Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA, warrants SNOAW) today
announced that financial results for its fiscal third quarter 2018,
ended December 31, 2017, will be released after the U.S. markets
close on February 7, 2018. The earnings release will be followed by
a conference call at 1:30 p.m. PST on February 7, 2018, to discuss
fiscal third quarter results.
Individuals interested in participating in the conference call
may do so by dialing 877-303-7607 for domestic callers or
973-638-3203 for international callers. Those interested in
listening to the conference call live via the internet may do so at
http://ir.sonomapharma.com/events.cfm. Please log on approximately
30 minutes prior to the presentation in order to register and
download the appropriate software. Also, participants can download
a graphical presentation of the quarterly results at this same
site, which can provide greater granular detail in conjunction with
the call.
A telephone replay will be available for seven days following
the conclusion of the call by dialing 855-859-2056 for domestic
callers, or 404-537-3406 for international callers, and entering
conference code 5949729. A webcast replay will be available on the
site at http://ir.sonomapharma.com/events.cfm for one year
following the call.
About Sonoma Pharmaceuticals, Inc.Sonoma
Pharmaceuticals (formerly Oculus Innovative Sciences) is a
specialty pharmaceutical company that develops and markets
solutions for the treatment of dermatological conditions and
advanced tissue care. The company's products, which are sold
throughout the United States and internationally, have improved
outcomes for more than five million patients globally by reducing
infections, itch, pain, scarring and harmful inflammatory
responses. The company's headquarters are in Petaluma, California,
with manufacturing operations in the United States and Latin
America. European marketing and sales are headquartered in
Roermond, Netherlands. More information can be found at
www.sonomapharma.com
Media and Investor Contact:
Sonoma Pharmaceuticals, Inc.Dan McFaddenVP of
Public and Investor Relations(425)
753-2105dmcfadden@sonomapharma.com
Sonoma Pharmaceuticals (NASDAQ:SNOA)
Historical Stock Chart
From Feb 2024 to Mar 2024
Sonoma Pharmaceuticals (NASDAQ:SNOA)
Historical Stock Chart
From Mar 2023 to Mar 2024